Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-204-4 | CAS number: 68334-05-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented publication meeting basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Cytogenetic Evaluation of Di-(2-ethylhexyl)phthalate and Its Major Metabolites in Fischer 344 Rats
- Author:
- Putman, D.L. et al.
- Year:
- 1 983
- Bibliographic source:
- Environmental Mutagenesis 5, 227-231
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- highest dose did not produce any indication of toxicity, such as reduction in mitotic index, only 50 instead of 100 cells per animals were analysed
- Principles of method if other than guideline:
- The cytogenetics assay was performed according to a modification of the procedures described by Kilian et al [1977].
- GLP compliance:
- not specified
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- 2-ethylhexan-1-ol
- EC Number:
- 203-234-3
- EC Name:
- 2-ethylhexan-1-ol
- Cas Number:
- 104-76-7
- Molecular formula:
- C8H18O
- IUPAC Name:
- 2-ethylhexan-1-ol
- Details on test material:
- - Name of test material (as cited in study report): 2-Ethylhexanol
- CAS No. of test material (as cited in study report): 104-76-7
- Analytical purity: 99.7 %
- Impurities (identity and concentrations): 0.3% 2-ethyl-4-methyl pentanol
- Source: Union Carbide
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Kingston, NY
- Age at study initiation:
- Assigned to test groups randomly: yes
- Weight at study initiation: 150-190 g
- Housing: three to four per cage during the quarantine period and one per cage during treatment on hardwood chips.
- Diet: free access to certified laboratory chow
- Water: ad libitum
- Acclimation period: 10-14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°F): 74ºF ±6ºF
- Humidity (%): 50 +/-20
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Duration of treatment / exposure:
- 5 consecutive days
- Frequency of treatment:
- daily
- Post exposure period:
- The rats were sacrificed by carbon dioxide asphyxiation 6 hours after the last dose
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 0.21, 0.07 and 0.02 mL/kg bw/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- A triethylenemelamine (TEM)-positive control group received a single intraperitoneal injection of 0.5 mg/kg TEM one day prior to sacrifice.
Examinations
- Tissues and cell types examined:
- Bone marrow cells
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
The dose levels, the highest of which represented approximately one-tenth of the five-day LD50, were based on a preliminary five-day dose-finding study
TREATMENT
The rats were sacrificed by carbon dioxide asphyxiation six hr after the last dose, the femurs were removed, and the bone marrow flushed into Hanks' balanced salt solution. After centrifugation at 600-800g for 8-10 min, the cells were treated with 0.075 M KCI for 20-30 min at 37°C. The cells were again centrifuged and washed twice with 5 mL of Carnoy's fixative. The cells were re-suspended in 5 mL of Carnoy's fixative and allowed to stand overnight at 4°C. The cells were then centrifuged and re-suspended to opalescence in fresh Carnoy's fixative. Two to five slides were prepared from each animal. Slides were stained with Giemsa and permanently mounted.
A minimum of 50 metaphase spreads from each animal was scored for chromatid and chromosomal gaps, breaks, and fragmentation, structural rearrangements, and ploidy [Cohen and Hirschorn, 1971; Kilian et al, 1977; Legator et al, 1973].
Spreads were selected for evaluation by systematic scanning of slides. Only cells which appeared intact with the chromosomes spread symmetrically, with no other metaphase cells intruding into the vicinity, and which contained no less than 36 chromosomes, were scored. In addition, the mitotic index (mitosis/100 cells) was recorded for each test animal. - Statistics:
- chi-square or Student's t-statistics
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
The results of the preliminary five-day oral toxicity studies indicated that the five-day LD50 for 2-ETHYLHEXANOL was 2.1 mL/kg/day.
Based on these data, the dose levels selected for the cytogenetics assay were 0.21, 0.07, and 0.02 ml/kg/day for 2-ETHYLHEXANOL.
RESULTS OF DEFINITIVE STUDY
There were no overt toxicological signs in any test or control animal during the five-day treatment period. The number of cells with chromosomal aberrations for 2-ETHYLHEXANOL-treatment groups was not statistically (P >0.05) increased relative to the corn oil control group. In addition, there were no apparent changes in the percentage of aneuploid cells or mitotic index. The number of chromatid gaps was increased; however, since the genetic significance of chromatid gaps is not clearly understood, they were not included in determination of number of metaphases with aberrations or total number of cells with one or more aberrations.
The positive controls, on the other hand, demonstrated severe damage, with approximately 26% of all cells analyzed containing one or more aberrations.
Based on the results of this study, it is concluded that under the conditions of the test, 2-ETHYLHEXANOL did not induce detectable chromosomal damage after oral administration.
Any other information on results incl. tables
Table 1: Results of chromosome aberration study in rats with 2-ethylhexanol (EH)
Treatment |
No. of animals |
No. of metaphases |
Mitotic indexa |
Gapsb |
Metaphases with aberrationsc |
Breaksd |
No. of metaphases with rearrangements |
Severely damaged cells |
|
No. |
% |
||||||||
Corn oil (5 mL/kg bw/d) |
5 |
250 |
4.8 |
2 |
0 |
0 |
0 |
0 |
0 |
0.2 mL/kg bw/d EH |
5 |
250 |
3.7 |
13 |
1 |
0.4 |
1 |
0 |
0 |
0.07 mL/kg bw/d EH |
5 |
250 |
4.1 |
13 |
1 |
0.4 |
1 |
0 |
0 |
0.02 mL/kg bw/d EH |
5 |
250 |
5.0 |
15 |
0 |
0 |
0 |
0 |
0 |
TEM 0.5 mg/kg bw |
5 |
250 |
4.2 |
71 |
66 |
26.4 |
54 |
19 |
43 |
aNumber of cells in mitosis per 100 cells.
bThe number of chromatid gaps were recorded for each treatment group; however, since their genetic significance is not clearly understood, they were not included in the assessment of chromosomal damage.
cIncludes metaphases with breaks and rearrangements.
dBreaks were of chromatid type only for treated animals.
eSeverely damaged cells, ie, cells having more than 10 aberrations.
Of the 50 metaphase bone marrow cells examined from each animal, no significant increase in chromatid and chromosome breaks or structural rearrangements were noted. The mitotic index, determined from 100 cells per animal was unaffected.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.